DESTINY PHARMA LIMITED

Company number 03167025

Date	Type	Description	View / Download
26 Oct 2017	MA	Memorandum and Articles of Association	(42 pages)
07 Sep 2017	CH01	Director's details changed for Mr Peter Morgan on 7 September 2017	(2 pages)
07 Sep 2017	CH01	Director's details changed for Dr William Guy Love on 7 September 2017	(2 pages)
07 Sep 2017	CH01	Director's details changed for Mr Anthony Joseph Eagle on 7 September 2017	(2 pages)
07 Sep 2017	SH01	Statement of capital following an allotment of shares on 4 September 2017 GBP 416,517.7	(3 pages)
30 Aug 2017	RESOLUTIONS	Resolutions RES01 ‐ Resolution of adoption of Articles of Association RES11 ‐ Resolution of removal of pre-emption rights	(45 pages)
24 Aug 2017	TM01	Termination of appointment of Geoffrey Howard Matthews as a director on 24 August 2017	(1 page)
24 Aug 2017	TM01	Termination of appointment of Jemima Elizabeth Wade as a director on 24 August 2017	(1 page)
24 Aug 2017	TM01	Termination of appointment of David Vaughan Scott as a director on 2 June 2017	(1 page)
24 Aug 2017	TM02	Termination of appointment of William Guy Love as a secretary on 2 June 2017	(1 page)
22 Aug 2017	BS	Balance Sheet	(7 pages)
22 Aug 2017	AUDS	Auditor's statement	(1 page)
22 Aug 2017	MAR	Re-registration of Memorandum and Articles	(26 pages)
22 Aug 2017	AUDR	Auditor's report	(1 page)
22 Aug 2017	RESOLUTIONS	Resolutions RES02 ‐ Resolution of re-registration	(3 pages)
22 Aug 2017	RR01	Re-registration from a private company to a public company including appointment of secretary(s)	(5 pages)
22 Aug 2017	RESOLUTIONS	Resolutions RES15 ‐ Change company name resolution on 2017-08-21	(3 pages)
22 Aug 2017	CONNOT	Change of name notice	(2 pages)
15 Aug 2017	TM01	Termination of appointment of David Roblin as a director on 30 May 2017	(1 page)
15 Jun 2017	AA	Accounts for a small company made up to 31 December 2016	(16 pages)
04 May 2017	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(1 page)
20 Mar 2017	CS01	Confirmation statement made on 4 March 2017 with updates	(15 pages)
11 Feb 2017	RESOLUTIONS	Resolutions RES13 ‐ Re-share premium 23/01/2017	(1 page)
11 Feb 2017	SH01	Statement of capital following an allotment of shares on 24 January 2017 GBP 319,180.00	(4 pages)
31 Jan 2017	AP01	Appointment of Mr Neil Robert Clark as a director on 20 January 2017	(2 pages)